1. Cytotoxicity and metabolism of prednimustine, chlorambucil and prednisolone in a Chinese hamster cell line

   • Beryl Hartley-Asp
   • Per Olov Gunnarsson
   • Jan Liljekvist

   Original Articles Pages: 85 - 90

2. Lack of experimental vesicant activity for the anticancer agents cisplatin, melphalan, and mitoxantrone

   • Robert T. Dorr
   • David S. Alberts
   • Michelle Soble

   Original Articles Pages: 91 - 94

3. In vivo and in vitro anticancer activity of the structurally novel and highly potent antibiotic CI-940 and its hydroxy analog (PD 114,721)

   • Billy J. Roberts
   • Katherine L. Hamelehle
   • Wilbur R. Leopold

   Original Articles Pages: 95 - 101

4. Pretreatment with ICRF-187 provides long-lasting protection against chronic daunorubicin cardiotoxicity in rabbits

   • Eugene H. Herman
   • Victor J. Ferrans

   Original Articles Pages: 102 - 106

5. Disposition and metabolism of [14-¹⁴C] 4-demethoxydaunorubicin HCl (idarubicin) and [14-¹⁴C]daunorubicin HCl in the rat

   • Guido Zini
   • Gian Piero Vicario
   • Federico Arcamone

   Original Articles Pages: 107 - 115

6. Cell cycle effects of trimetrexate (CI-898)

   • Kenneth E. Hook
   • James M. Nelson
   • Wilbur R. Leopold

   Original Articles Pages: 116 - 120

7. Inhibitory effect of bile salts on the enterohepatic circulation of methotrexate in the unanesthetized rat: Inhibition of methotrexate intestinal absorption

   • Hamid M. Said
   • Daniel Hollander

   Original Articles Pages: 121 - 124

8. In vivo studies with the novel anticancer agent mitozolomide (NSC 353451) on Lewis lung carcinoma

   • Massimo Broggini
   • Eugenio Erba
   • Maurizio D'Incalci

   Original Articles Pages: 125 - 128

9. Antitumor action of N-(2-chloroethyl)-N-nitrosocarbamoyl derivatives of biologically active polypeptide hormone fragments

   • A. Jeney
   • L. Kopper
   • K. Medzihradszky

   Original Articles Pages: 129 - 132

10. Calmodulin and alpha tocopherol as additional binding sites for doxorubicin

    • Reginald N. P. Nwankwoala
    • William L. West

    Original Articles Pages: 133 - 138

11. The antitumour effect and toxicity of cis-platinum and N-methylformamide in combination

    • Ernest S. Harpur
    • Simon P. Langdon
    • John Ishmael

    Original Articles Pages: 139 - 147

12. In vitro comparative studies of the myelotoxicity and antitumor activity of 6-[bis-(2-chloroethyl)-amino]-6-deoxy-D-glucose versus melphalan utilizing the CFU-C and HTSCA assays

    • Philip Lazarus
    • Maurice Dufour
    • Lawrence C. Panasci

    Original Articles Pages: 148 - 152

13. The effect of disulfiram on cyclophosphamide-mediated myeloid toxicity

    • Richard L. Gamelli
    • William B. Ershler
    • Roger S. Foster

    Original Articles Pages: 153 - 155

14. Clinical pharmacolinetics of 9, 10-anthracenedicarboxaldehyde-bis [(4,5-dihydro-1H-imidazol-2-yl)hydrazone]dihydrochloride

    • Katherine Lu
    • Niramol Savaraj
    • Ti Li Loo

    Original Articles Pages: 156 - 159

15. Phase I and pharmacokinetic study of tiazofurin (NSC 286193) administered by 5-day continuous infusion

    • D. Raghavan
    • J. Bishop
    • R. Fox

    Original Articles Pages: 160 - 164

16. Treatment of advanced neuroblastoma with high-dose melphalan and autologous bone marrow transplantation

    • O. Hartmann
    • C. Kalifa
    • J. Lemerle

    Original Articles Pages: 165 - 169

17. Very high dose chemotherapy with autologous bone marrow rescue in adult patients with resistant relapsed lymphoma

    • C. C. Anderson
    • A. H. Goldstone
    • J. D. M. Richards

    Original Articles Pages: 170 - 175

18. Intravesical chemotherapy with 4′-epi-Adriamycin in patients with superficial bladder tumors

    • Yosuke Matsumura
    • Tomoyasu Tsushima
    • Hiroyuki Ohmori

    Original Articles Pages: 176 - 177

19. The effect of dose on the bioavailability of oral etoposide

    • Vernon J. Harvey
    • Maurice L. Slevin
    • Peter F. M. Wrigley

    Original Articles Pages: 178 - 181

20. Phase I study of cyclohexylamine and lysine salt of mafosfamide

    • Reto Abele
    • Matti S. Aapro
    • Pierre Alberto

    Original Articles Pages: 182 - 183

21. Pharmacokinetics of high-dose melphalan in children and adults

    • Alain Gouyette
    • Olivier Hartmann
    • José-Luis Pico

    Original Articles Pages: 184 - 189

22. Pharmacokinetics of erythrocyte methotrexate in children with acute lymphoblastic leukemia during maintenance treatment

    • Henrik Schrøder
    • Niels Clausen
    • Tania Pressler

    Original Articles Pages: 190 - 193

23. The effect of food on oral melphalan absorption

    • Phillip A. Reece
    • Dusan Kotasek
    • Robert E. Sage

    Original Articles Pages: 194 - 197

24. Pharmacokinetics in experimental and clinical chemotherapy

    • Paul Workman

    Letter to the Editor Pages: 198 - 199

25. Acknowledgements to reviewers

    Acknowledgments Pages: 200 - 200

26. Meeting announcements

    Announcement Pages: 201 - 201